Canaccord Genuity hosts 30th Annual Growth Conference August 10-12, 2010: Boston

04 August 2010

BOSTON – August 4, 2010 – Canaccord Genuity is pleased to announce the line-up for its 30th Annual Growth Conference, a premier investment forum for innovative small and mid-cap growth companies from the US, Canada, and the UK.  The Boston-based conference demonstrates Canaccord Genuity’s focus on bringing institutional investors some of the most interesting and actionable ideas from a growing, global universe of small and mid-cap companies.  At the conference, institutional and private investors, as well as venture capitalists, are provided with the opportunity to speak directly with the management teams of over 300 public and private companies.

“For thirty years investors have gained valuable insight into growth companies and have benefitted from investment opportunities from our Growth Conference,” noted Paul Reynolds, President and CEO of Canaccord Financial Inc.  “The popularity of the conference is testament to the quality and range of companies showcased at the event.  It is an important forum for many emerging businesses and the investors who see potential in their growth.”

“Our 30th Annual Growth conference will be of particular interest to investors given the recent market volatility” said Jamie Brown, President and Head of US Investment Banking, Canaccord Genuity Inc. “This week will provide investors access to growth companies whose prospects and track records can be reflected in their share price, regardless of market conditions.”

The key sectors represented at this year’s conference reflect the industries followed by Canaccord Genuity’s global research team: technology, life sciences, real estate, consumer, sustainability and infrastructure.  More than 240 small and mid-cap growth companies will be presenting at the conference, along with over 50 selective companies at the Private Company Showcase. 

A number of in-depth “Knowledge Sessions” will also explore important industry themes, changes and trends. These panels will be comprised of industry experts, Canaccord research analysts, and venture capital professionals. Most of the presenting public companies are covered by Canaccord Genuity’s global team of equity analysts. 

For detailed descriptions of our Knowledge Sessions, visit


3D Systems Corp (TDSC), Achillion (ACHN), Acuity Brands (AYI), Advanced Analogic Tech (AATI), Aeterna Zentaris (AEZS), AIXTRON (AIXG), Algonquin Power (TSX: AQN), Allergan, Inc. (AGN), Allon Therapeutics Inc. (TSX:NPC), Allos Therapeutics, Inc. (ALTH), Alphatec Spine, Inc. (ATEC), AMAG Pharmaceuticals (AMAG), Amarin (AMRN), AngioDynamics, Inc. (ANGO), (ANSW), Antisoma plc (ASM), API Technology (ATNY.OB), Apogee Enterprises Inc. (APOG), ArthroCare Corporation (ARTC), Asia Bio-Chem Group Co. Ltd. (TSX: ABC), AspenBio Pharma, Inc. (APPY), Astec (ASTE), Atheros Communications (ATHR), Atricure (ATRC), AuthenTec (AUTH), Avanir Pharmaceuticals, Inc (AVNR), AVEO Pharmaceuticals (AVEO), Avid Technology (AVID), Baldor Electric Company (BEZ), BioExx Specialty Proteins (TSX: BXI), BioMimetic Therapeutics (BMTI), BioteQ Environmental Technologies Inc. (TSX: BQE), blinkx (AIM :BLNX), Bottomline Technologies (EPAY), Bridgewater Systems (TSX: BWC), Brocade Communication Systems (BRCD), Cadence Pharmaceuticals (CADX), Canadian Solar (CSIQ), Capital Power (TSX: CPX), Cascade Microtech, Inc. (CSCD), Casella Waste Systems (CWST), Cash Store Financial (TSX: CFS; NYSE:), China Biologic Products (CBPO), China Gerui Advanced Materials Group Ltd. (CHOP), China XD Plastics Company (CXDC), Churchill Corp (CUQ),  Clarient, Inc. (CLRT), Coinstar (CSTR), ComScore (SCOR), Constant Contact (CTCT), Cortex Business Solutions (CBX.V), Cynosure, Inc. (CYNO), Cytokinetics, Inc. (CYTK), Datalink (DTLK), Delcath Systems, Inc. (DCTH), Demandware (TSX: DWI), Dendreon Corp (DNDN), Descartes (DSGX), Dexcom (DXCM), Dialight Corp. (DIA), Dialog Semiconductor Plc (XTRA: DLG), DigitalGlobe (DGI), Dolby Laboratories (DLB), DragonWave (TSX: DWI), Echelon (ELON), Emera (TSX: EMA), Emulex Corporation (ELX), Endologix (ELGX), EnerNOC (ENOC), EnteroMedics (ETRM), Epicor Software Corp (EPIC), ESCO Technologies (ESE), Evergreen Solar, Inc. (ESLR), EXACT Sciences Corporation (EXAS), Exactech. Inc. (EXAC), Exelixis Pharmaceuticals (EXEL), F5 Networks (FFIV), FFastFill (AIM: FFA), First Solar (FSLR), Fuel Cell Energy (FCEL), Fuel Systems Solutions (FSYS), Fuel Tech (FTEK), Gennum Corporation (TSX: GND), GeoEye (GEOY), Glacier Media (TSX: GVC), GLG Life Tech Corp. (GLGL), Greatbatch (NYSE: GB), Green Mountain Coffee Roasters (GMCR), GuestLogix Inc. (TSX: GXI), Hanfeng Evergreen Inc. (TSX: HF), Headwaters, Inc. (HW), HeartWare (Nasdag: HTWR), Hemisphere GPS (TSX: HEM), Herbalife International (HLF), Hologic, Inc. (HOLX), Horsehead Corporation (ZINC), IBI Group (TSX:IBG), iCAD, Inc. (ICAD), ICF International (ICFI), ImmunoGen (IMGN), IMRIS (TSX:IM), Inhibitex (INHX), Insulet (PODD), Integra LifeSciences (IART), Intermap Technologies (TSX: IMP), InterMune, Inc. (ITMN), Internet Brands (INET), Inverness Medical Innovations Inc (IMA), IQE (LSE: IQE), Itron, Inc. (ITRI), Jamba Juice Company (JMBA), Kadant (KAI), KIT digital, Inc (KITD), KMG Chemicals (KMGB), Kofax plc (LSE: KFX), Labopharm (DDSS), LeMaitre Vascular (LMAT), LG Innotek, Lighting Science Group Corp (LSCG), LIME Energy (LIME), LioNBRIDGE Technologies (LIOX), LivePerson, Inc. (LPSN), (LOCM), LogMeIn (LOGM), LSB Industries (LXU), Luminex Corporation (LMNX), Magma Design Automation (LAVA), MAKO Surgical Corp (MAKO), Mannkind Corporation (MNKD), Marchex. Inc (MCHX), Martek Biosciences Corporation (MATK), Marina Biotech (MRNA), Medifast, Inc. (MED), Metalico Inc (MEA), Micromet (MITI), Migao Corporation (TSX: MGO), Mitel Networks (MITL), MKS Instruments (MKSI), Momenta Pharmaceuticals, Inc (MNTA), Monotype Imaging (TYPE), Multiplied Media Corporation (TSX: MMC), Nalco Holding Company (NLC), NCI Building Systems (NCS), NetScout Systems, Inc. (NTCT), NeuroMetrix (NURO), Newalta (TSX:NAL), Nexxus Lighting (NEXS), NPS Pharmaceuticals (NPSP), Nu Skin Enterprises (NUS), Nuance Communication (NUAN), NxStage Medical, Inc. (NXTM), Obagi (OMPI), Omeros (OMER), Oncolytics Biotech, Inc. (TSX: ONC), Onyx Pharmaceuticals (ONXX), Optimer Pharmaceuticals, Inc. (OPTR), Orasure Technologies (OSUR), Orexigen Therapeutics (OREX), Orion Energy Systems (OESX), OrthoFix (OFIX), Orthovita (VITA), Osteotech (OSTE), Palomar Medical Technologies, Inc (PMTI), Parametric Technology (PMTC), Pegasystems Inc. (PEGA), Perficient, Inc. (PRFT), Pharmasset, Inc (VRUS), Planet Payment (AIM:PPT), Plutonic Power (TSX: PCC), PowerSecure International (POWR), Progress Software (PRGS), Protalix BioTherapeutics (PLX), Pure Technologies (TSX: PUR), QLogic (QLGC), Quidel (QDEL), ReachLocal (RLOC), Redknee (TSX: RKN), ResMed Inc. (RMD), Riverbed Technology, Inc. (RVBD), Rocky Mountain Dealerships (TSX: RME), Rovi Corporation (ROVI), RTI Biologics (RTIX), Rubicon Technology, Inc. (RBCN), (SLRY), Sandvine (TSX:SVC), Satcon Technology Corporation (SATC), Schnitzer Steel (SCHN), Seattle Genetics Inc. (SGEN), Silicon Motion (SIMO), Sino-Forest Corporation (TSX: TRE), SinoHub (SIHI), Solarfun (SOLF), Solta Medical (SLTM), Sonic Solutions (SNIC), Spectranetics Corporation (SPNC), SPS Commerce (SPSC), STAAR Surgical Company (STAA), Standard Microsystems (SMSC), Stantec (TSX: STN), Stryker Corp. (SYK), Summer Infant (SUMR), SunOpta, Inc. (STKL), Supertex Inc. (SUPX), Synta Pharmaceuticals Corp (SNTA), Tech Target (TTGT), Telenav (TNAV), Telvent (TLVT), Theratechnologies Inc. (TSX: TH), Thoratec Corporation (THOR), Transition Therapeutics, Inc. (TTHI), Trex Company (TREX), Trimble Navigation Ltd. (TRMB), TSO3 (TSX:TOS), Ultimate Software (ULTI), Unica Corp (UNCA), United Natural Foods (UNFI), Universal Display (PANL), USANA Health Sciences, Inc. (USNA), Valueclick (VCLK), Vascular Solutions (VASC), Veeco Instruments (VECO), Vertex Pharmaceuticals (VRTX), Vical Inc. (VICL), Vocus (VOCS), Volcano Corporation (VOLC), Voltaire (VOLT), Volterra (VLTR), WaterFurnace Renewable Energy, Inc. (TSX: WFI), Wave Systems Corporation (WAVX), WebMD Corporation (WBMD), Wi-Lan (TSX: WIN), Ziopharm Oncology Inc. (ZIOP), Zongshen PEM (TSX: ZPP), Zoran (ZRAN) and Zymogenetics (ZGEN).

The 2010 Private Company Showcase will focus on 50+ select early- to mid-stage technology, consumer, life sciences and sustainability companies.  Most of the companies have completed initial product development and are launching or expanding product commercialization.


Actel Corporation, Adenyo, Advanced Electron Beams, Angie’s List, Aspen Aerogels, Avigilon Corporation, Barrett Xplore, Beyond the Rack, Biocius Life Sciences, Biolex Therapeutics, Inc., Black Duck Software, BlueArc Corporation, Brainshark, BrandMuscle, Inc., BTI Systems, CambridgeSoft Corporation, Carbonite, Concert Pharmaceuticals, Control4, EcoSynthetix Inc, Ember, Ethoca, Extreme Reach, Fresco Microchip, Grid Net, Illumitex, Inc, Ingres, Inrix, Intarcia, Landis + Gyr, LipoScience, Oversight Systems, Plex Systems, Plumchoice, Inc., RecycleBank, Rivermine, Sage Electrochromics, Inc., Serious Materials, Skyhook Wireless, SmartSynch, Syncapse, Tantalus Systems, The Receivables Exchange, Tranzyme, Inc., Trius Therapeutics, Tropos Networks, Violin Memory, WindTronics, Xiotech, Xunlight,

Back to Listing